BGB-102

Item number	Size	Delivery time	Price
TGM-T10531-1mg	1 mg	7 - 10 business days*	310.00€
TGM-T10531-5mg	5 mg	7 - 10 business days*	774.00€
TGM-T10531-10mg	10 mg	7 - 10 business days*	1,023.00€
TGM-T10531-25mg	25 mg	7 - 10 business days*	1,545.00€
TGM-T10531-50mg	50 mg	7 - 10 business days*	2,076.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an... more

Close menu

Product information "BGB-102"

Description: BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations. Target: Src, EGFR, FLT, VEGFR. Smiles: BrC1=CC=C2C(=C1)NC=3N=CN=C4C=C(OC)C(OCCCCCN(C)C2)=CC43. References: Gijsen M, et al. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010 Dec 21,8(12):e1000563.

Keywords:	JNJ-26483327
Supplier:	TargetMol
Supplier-Nr:	T10531

Properties

MW:	457.36 D
Formula:	C22H25BrN4O2

Database Information

CAS :

807640-87-5| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BGB-102"

Write a review